Analyses of Gonadoblastoma Y (GBY)-locus and of Y Centromere in Turner Syndrome Patients

Abstract

Background: Mosaicism with cytogenetically visible Y chromosome is found in 5–6% of Turner Syndrome (TS) patients. Additionally, occult Y-chromosome derived material is increasingly found in patients with monosomy X when using more sensitive molecular techniques. These TS patients are at risk of developing gonadoblastomas when the Y genes presumed to be involved in gonadoblastoma development (Gonadoblastoma-Y-locus; GBY) are present.

Aim: To find occult Y-chromosome material in TS patients and to correlate the patient’s phenotype to Y-chromosome material.

Methods: We studied 60 TS-patients for presence of the Y chromosome with focus on the Gonadoblastoma Y-locus and its extension in Yp and Yq using sensitive Y centromere and Y gene deletion PCR assays. In addition, we evaluated their individual clinical and auxological characteristics.

Results: We identified presence of the GBY-locus in 7 patients (11.7%) including 4 patients without evidence for a Y chromosome in their preceding standard karyotype analyses. Clinical and auxological characteristics were similar in GBY-positive and GBY-negative patients.

Conclusions: Presence of the GBY locus in Turner patients with no indication of the Y chromosome in standard cytogenetic chromosome analysis can be revealed by sensitive molecular PCR assays screening for presence of the Y centromere and the GBY-candidate-genes in proximal Yp11 and Yq11, respectively.

Key words

molecular genetics - karyotype - Y-mosaicism - disorders of sex differentiation

• References

• 1 Sybert VP, McCauley E. Turner’s Syndrome. N Engl J Med 2004; 351: 1227-1238
• 2 Quincy Zhong BS, Lawrence C, Layman MD. Genetic Considerations in the patient with Turner syndrome – 45,X with or without mosaicism. Fertil Steril 2012; 4: 775-779
• 3 Mazzanti L, Cicognani A, Baldazzi L et al. Gonadoblastoma in Turner Syndrome and Y-Chromosome-Derived Material. Am J Med Genet A 2005; 135: 150-154
• 4 Verp MS, Simpson J. Abnormal sexual differentiation and neoplasia. Cancer Genet Cytogenet 1987; 25: 191-218
• 5 Alvarez-Nava F, Soto M, Sanchez A et al. Molecular Analysis in Turner Syndrome. J Pediatr 2003; 142: 336-340
• 6 Gravholt CH, Felder J, Naera RW et al. Occurrence of Gonadoblastoma in Females with Turner Syndrome and Y Chromosome Material: A Population Study. J Clin Endocrinol Metab 2000; 85: 3199-3202
• 7 Cools M, Drop SL, Wolffenbuttel KP et al. Germ cell tumours in the intersex gonad: old paths, new directions, moving frontiers. Endocr Rev 2006; 27: 468-484
• 8 Tsuchiya K, Reijo R, Page DC et al. Gonadoblastoma: Molecular Definition of the Susceptibility Region on the Y Chromosome. Am J Hum Genet 1995; 57: 1400 - 1407
• 9 Muroya K, Ishii T, Nakahori Y et al. Gonadoblastoma mixed germ cell tumor, and Y chromosomal genotype: molecular analysis in four patients. Genes, Chromosomes & Cancer 1999; 25: 40-45
• 10 Vogt PH, Ditton HJ, Kamp C et al. Structure and function of AZFa locus in human spermatogenesis. In: Lau Y-FC, Chan WY. (eds.) The Y chromosome and male germ cell biology in health and diseases. World Scientific Publishing Co. Ltd; 2007: 91-126
• 11 Lau YF, Li Y, Kido T. Gonadoblastoma locus and the TSPY gene on the human Y chromosome. Birth Defects Res C Embryo Today 2009; 87: 114-122
• 12 Brandt I, Reinken L. Growth Velocity for Supine Length/Height of Normal Children from Birth to 16 Years: Longitudinal Study Bonn – Dortmund. Klin Pädiatr 1998; 200: 451-456
• 13 Kromeyer-Hauschild K, Wabitsch M, Kunze D et al. Percentiles of body mass index in children and adolescents evaluated from different regional German studies. Monatsschr Kinderheilk 2001; 149: 807-818
• 14 Voigt M, Fusch C, Olbertz D et al. Analysis of the Neonatal Collective in the Federal Republic of Germany. Geburtsh Frauenheilk 2006; 66: 956-970
• 15 Vogt PH, Falcao CL, Hanstein R et al. The AZF proteins. Int J Androl 2008; 31: 383-394
• 16 Vogt PH, Bender U. Human Y chromosome microdeletion analysis by PCR multiplexprotocols identifying only clinically relevant AZF microdeletions. Methods Mol Biol 2013; 927: 187-204
• 17 Patsalis PC, Sismani C, Hadjimarcou MI et al. Detection and incidence of cryptic Y chromosome sequence in Turner syndrome patients. Clin Genet 1998; 53: 249-257
• 18 Canto P, Kofman-Alfaro S, Jimenez AL et al. Gonadoblastoma in Turner syndrome patients with nonmosaic 45, X karyotypes and Y chromosome sequence. Cancer Genet Cytogenet 2004; 150: 70-72
• 19 Bianco B, Lipay MV, Melaragno MI et al. Detection of hidden Y mosaicism in Turner’s syndrome: importance in the prevention of gonadoblastomas. Pediatr Endocrinol Metab 2006; 19: 1113-1117
• 20 Binder G, Koch A, Wajs E et al. Nested polymerase chain reaction study of 53 cases with Turner’s syndrome: is cytogenetically undetected Y mosaicism common?. J Clin Endocrinol Metab 1995; 80: 3532-3536
• 21 Cools M, Pleskacova H, Stoop P et al. Mosaicism Collaborative Group . Gonadal Pathology and Tumor Risk in Relation to Clinical Characteristics in Patients with 45,X/46,XY Mosaicism. J Clin Endocrinol Metab 2011; 96: E1171-E1180
• 22 Alvarez-Nava F, Gonzalez S, Soto S et al. Mixed Gonadal Dysgenesis: a Syndrome of broad clinical, cytogenetic and histopathologic spectrum. Genet Couns 1999; 10: 233-243
• 23 Mancilla EE, Poggi H, Repetto G et al. Y chromosome sequences in Turner’s syndrome: association with virilization and gonadoblastoma. J Clin Endocrinol Metab 2003; 16: 1157-1163
• 24 Sallai A, Sólyom J, Dobos M et al. Y-chromosome markers in Turner syndrome: Screening of 130 patients. J Endocrinol Invest 2010; 33: 222-227
• 25 Salo P, Kääriäinen H, Petrovic V et al. Molecular mapping of the putative gonadoblastoma locus on the Y chromosome. Genes Chromosomes Cancer 1995; 14: 210-214
• 26 De Arce MA, Costigan C, Gosden JR et al. Further evidence consistent with Yqh as an indicator of risk of gonadal blastoma in Y-bearing mosaic Turner syndrome. Clin Genet 1992; 41: 28-32